Connor, Clark & Lunn Investment Management (CC&L)’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
HRCM
NAMI
Connor, Clark & Lunn Investment Management (CC&L)'s ATRC Position: Q2 2026 in Review
Connor, Clark & Lunn Investment Management (CC&L) reduced its AtriCure (ATRC) stake by 2.9% in Q2 2026, selling an estimated $277K and leaving 335,541 shares worth $9.39M. The position accounts for 0.02% of the portfolio, ranked #555.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in ATRC in Q3 2018 and has held it in 18 quarters since. The position peaked at $15M in Q4 2025. 252 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.
- Connor, Clark & Lunn Investment Management (CC&L) held 335,541 shares of AtriCure worth $9.39M as of Q2 2026.
- Connor, Clark & Lunn Investment Management (CC&L) sold 9,847 AtriCure shares in Q2 2026, an estimated $277K.
- AtriCure made up 0.02% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q2 2026, its #555 holding.
- Connor, Clark & Lunn Investment Management (CC&L) first reported a position in AtriCure in Q3 2018 and has held it in 18 quarters since.
- Connor, Clark & Lunn Investment Management (CC&L)'s AtriCure position peaked at $15M in Q4 2025.
- 252 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.
Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2026, filed 13 Aug 2026.